AZN receives accelerated approval for breast cancer treatment
AZN says the FDA has granted accelerated approval for a new breast cancer treatment.
Story updates
07:43:54 PM UTC
SquawkNews
US FDA Grants Accelerated Approval To AstraZeneca's Etcamah For Advanced Breast Cancer With ESR1 Mutation
07:53:54 PM UTC
SquawkNews
US FDA Grants Accelerated Approval To AstraZeneca's Etcamah For Advanced Breast Cancer With ESR1 Mutation
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.